Table 3 Comparison of models
Patients studied | R2 N | Hazard ratios (95% confidence interval) | |||
|---|---|---|---|---|---|
np | nx | np/nx (%) | L | ||
All cases | |||||
1: no nodal variables | 0.069 | ||||
2: np | 0.093 | 1.093 (1.090–1.097) | |||
3: nx | 0.069 | 0.998 (0.995–1.001) | |||
4: np, nx | 0.096 | 1.112 (1.108–1.116) | 0.970 (0.966–0.974) | ||
5: np/nx (%) | 0.104 | 1.023 (1.022–1.024) | |||
6: L | 0.108 | 1.459 (1.442–1.477) | |||
7: np, np/nx (%) | 0.104 | 1.010 (1.004–1.017) | 1.021 (1.020–1.023) | ||
8: nx, np/nx (%) | 0.104 | 1.002 (0.999–1.005) | 1.023 (1.022–1.024) | ||
9: np, L | 0.108 | 0.998 (0.992–1.005) | 1.466 (1.435–1.497) | ||
10: nx, L | 0.109 | 1.009 (1.006–1.013) | 1.462 (1.445–1.479) | ||
11: np, nx, np/nx (%) | 0.104 | 1.013 (1.004–1.022) | 0.998 (0.994–1.002) | 1.021 (1.019–1.022) | |
12: np, nx, L | 0.109 | 0.967 (0.957–0.976) | 1.021 (1.017–1.026) | . | 1.599 (1.554–1.646) |
Node-positive patients | |||||
1: no nodal variables | 0.067 | ||||
2: np | 0.095 | 1.066 (1.062–1.071) | |||
3: nx | 0.067 | 0.996 (0.992–1.000) | |||
4: np, nx | 0.102 | 1.088 (1.083–1.093) | 0.966 (0.961–0.971) | ||
5: np/nx (%) | 0.108 | 1.017 (1.016–1.018) | |||
6: L | 0.108 | 1.379 (1.355–1.403) | |||
7: np, np/nx (%) | 0.109 | 1.013 (1.006–1.020) | 1.015 (1.014–1.017) | ||
8: nx, np/nx (%) | 0.108 | 1.005 (1.001–1.009) | 1.017 (1.016–1.018) | ||
9: np, L | 0.108 | 1.008 (1.001–1.016) | 1.344 (1.306–1.384) | ||
10: nx, L | 0.108 | 1.005 (1.001–1.009) | 1.381 (1.357–1.405) | ||
11: np, nx, np/nx (%) | 0.109 | 1.016 (1.005–1.028) | 0.998 (0.991–1.004) | 1.015 (1.013–1.017) | |
12: np, nx, L | 0.108 | 1.003 (0.990–1.017) | 1.003 (0.996–1.010) | 1.366 (1.304–1.431) | |
Node-negative patients | |||||
1: no nodal variables | 0.045 | NA | |||
3: nx | 0.045 | NA | 0.991 (0.986–0.997) | ||
6: L | 0.045 | NA | 1.150 (1.058–1.249) | ||
10: nx, L | 0.045 | NA | 1.001 (0.984–1.019) | 1.169 (0.902–1.514) | |